Cite
HARVARD Citation
Lundkvist, P. et al. (2017). Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes, obesity & metabolism. 19 (1), pp. 49-60. [Online].